Patent Challenges And Litigation On Inhalers For Asthma And COPD
Health Affairs · 2023
DOI: 10.1377/hlthaff.2022.00873 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Affairs, 2023. Verfasst von Sanjay Reddy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sanjay Reddy, Georgetown University, Washington, D.C. Hauptthemen laut MEDLINE: Asthma, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Themen: COPD
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sanjay Reddy, Georgetown University, Washington, D.C.
- Reed F. Beall, University of Calgary, Calgary, Alberta, Canada.
- S. Sean Tu, University of West Virginia, Morgantown, West Virginia.
- Aaron S. Kesselheim, Brigham and Women's Hospital and Harvard University, Boston, Massachusetts.
- William B. Feldman (wbfeldman@bwh.harvard.edu), Brigham and Women's Hospital and Harvard University.
Zitieren
APA
Reddy, S., Beall, R. F., Tu, S. S., Kesselheim, A. S., & Feldman, W. B. (2023). Patent Challenges And Litigation On Inhalers For Asthma And COPD. Health Affairs. https://doi.org/10.1377/hlthaff.2022.00873
Vancouver
Reddy S, Beall RF, Tu SS, Kesselheim AS, Feldman WB. Patent Challenges And Litigation On Inhalers For Asthma And COPD. Health Affairs. 2023. doi:10.1377/hlthaff.2022.00873
BibTeX
@article{Reddy2023,
author = {Reddy, Sanjay and Beall, Reed F and Tu, S Sean and Kesselheim, Aaron S and Feldman, William B},
title = {Patent Challenges And Litigation On Inhalers For Asthma And COPD},
journal = {Health Affairs},
year = {2023},
doi = {10.1377/hlthaff.2022.00873}
}
EUVIMED